Tucker et al from Georgetown University used the CCK antagonist proglumide in a mouse model of NASH and CCK, reporting the remarkable finding that reversed hepatic inflammation, fibrosis, and steatosis while preventing HCC development. https://t.co/SKohQ
715 followers
2,282 followers
RT @DrJHK: A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma https://t.co/RWrH…
2,282 followers
A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma https://t.co/RWrHoP5vsr
59 followers
A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma. https://t.co/fJRJS1Ke08